fluorodeoxyglucose f18 has been researched along with Hyperuricemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Cheng, J; He, F; Koyama, H; Liu, W; Lu, J; Wang, M; Wang, Q; Wang, W; Xi, Y; Xu, C; Yamamoto, T; Yan, Y; Yu, L; Yu, W; Zhang, C; Zhao, H | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and Hyperuricemia
| Article | Year |
|---|---|
Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway
Topics: AMP-Activated Protein Kinases; Animals; Cytokines; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Hyperuricemia; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Kupffer Cells; Mice; Phosphatidylinositol 3-Kinases; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Urate Oxidase; Uric Acid | 2022 |